Description
LXS-196 is a selective inhibitor of protein kinase C (PKC). It is being investigated as a treatment for metastatic uveal melanoma, and may exhibit antitumor effects in other advanced tumors characterized by the overexpression of PKC.
Product Unit Size | Cost | Quantity | Stock |
---|
LXS-196 is a selective inhibitor of protein kinase C (PKC). It is being investigated as a treatment for metastatic uveal melanoma, and may exhibit antitumor effects in other advanced tumors characterized by the overexpression of PKC.
Cas No. | 1874276-76-2 |
---|---|
Purity | ≥98% |
Formula | C22H23F3N8O |
Formula Wt. | 472.48 |
Chemical Name | LXS-196 |
IUPAC Name | 3-Amino-N-[3-(4-amino-4-methyl-1-piperidinyl)-2-pyridinyl]-6-[3-(trifluoromethyl)-2-pyridinyl]-2-pyrazinecarboxamide |
Synonym | LXS 196, LXS196, NVP-LXS196, Darovasertib |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Carbonic anhydrase inhibitor.
HDAC inhibitor.
TGR5 agonist.
5-HT1A agonist, D2, 5-HT1D antagonist.
Endogenous tachykinin peptide, involved in infl...
Selective inhibitor of LRRK2.
Peptide, c-Kit ligand fragment.
Purine, purvalenol A analog; CDK2, Cdc28p, Pho8...
Neuraminidase inhibitor.
Diterpene found in brewed, unfiltered coffee; F...
B-Raf inhibitor.
CRM1-selective inhibitor of nuclear export.
BH3 mimetic; Bcl-2, Bxl-xl, Bcl-w inhibitor.
RXR agonist.
Potential AhR binding agent.
Reduces production of thyroid hormones
Found in Aristolochia and Radix; PLA2 inhibitor...
Antihistamine with potential neuroprotective ac...
Bufanolide steroid found in Bufo arenarum;VEGFR...
Stearoyl-coA desaturase 1 inhibitor.